Readmissions in Severe Sepsis Common
“Severe sepsis continues to be a common cause of hospitalisation and has the associated high costs,” says lead author Darya Rudym, MD, New York University School of Medicine, New York.
Previous studies have examined some quality measures (eg, length of stay) associated with sepsis, an infection of the bloodstream that can lead to organ failure and death. Dr. Rudym's study specifically looked at the rate of readmission within 30 days after discharge with a diagnosis of severe sepsis. Dr. Rudym and colleagues sought to compare this rate to the readmission rates for Centers for Medicare and Medicaid Services reported outcomes such as acute myocardial infarction (MI), HF and pneumonia.
The research team studied inpatient discharges from Bellevue Hospital in New York City between July 2011 and July 2014 and identified subsequent readmissions to the hospital within 30 days.
During the three-year study period, the team tracked 22,712 discharges, with an overall readmission rate of 15.31 percent (3,477 patients). Based on three different previously reported methods of detecting cases of severe sepsis, namely Angus, Martin, and the explicit International Classification of Diseases-9-CM sepsis codes, 1,801, 798, and 579 patients, respectively, were identified as discharged with severe sepsis. “Of those, 266, 119, and 71 were readmitted within 30 days, accounting for 14.77 percent, 14.91 percent, and 12.26 percent, respectively,” explains Dr. Rudym.
In comparison, the readmission rates for MI, pneumonia and HF were 8.67 percent, 14.46 percent and 15 percent, respectively.
As Dr. Rudym points out: “Readmission rates in severe sepsis are shown not to be significantly different from readmission rates in heart failure and pneumonia.”
Source: American Thoracic Society
Image credit: NHS Direct Wales
Published on : Wed, 20 May 2015
Print as PDF
Always in sight, always in mind Features Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating...
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
Q-NRG is the first Indirect Calorimeter specifically intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing and for healthy subjects.Q-NRG is a unique product, resulting...
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery.All blood-contact surfaces of the NovaPort cannulas are coated with the bio- and...
The Accelerate PhenoTest™ BC kit is the first application of the Accelerate Pheno™ system. It provides with less 5 minutes operator hands-on time within 1.5 hour the identification of the most prevalent micro-organisms seen in blood stream infections....